Table 2.

Association of Clinical Experience of Clinician-Investigators and Frequency of Discussing Critical Elements of Consent during Informed Consent Conversations

Critical Element of Consent (CEC)	Median years of experience of investigators who discussed CEC during ICC?	Median years of experience of investigators who did not discuss CEC during ICC?	P-value
Study Purpose	14	20	0.48
Risk Side effects	15	16	0.27
Voluntariness	14	16	0.24
Withdrawal rights	14.5	16.5	0.10
Confidentiality	13.5	17	0.09
Dosing Cohorts	13	16	0.07
Dose escalation	14	16	0.96
Dose limiting Toxicity	9	16	0.006